- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/06 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
Patent holdings for IPC class C07D 231/06
Total number of patents in this class: 249
10-year publication summary
|
19
|
16
|
20
|
6
|
12
|
27
|
12
|
19
|
14
|
12
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2851 |
16 |
| The Regents of the University of California | 19918 |
12 |
| Sironax LTD | 50 |
8 |
| Bayer Cropscience AG | 2035 |
7 |
| Jenrin Discovery, Inc. | 10 |
7 |
| Board of Regents, The University of Texas System | 5793 |
6 |
| Merck Patent GmbH | 5831 |
5 |
| Glaxosmithkline Intellectual Property Development Limited | 762 |
5 |
| AnaMar AB | 14 |
5 |
| Jenrin Discovery | 15 |
5 |
| Bristol-myers Squibb Company | 4898 |
4 |
| BASF SE | 20933 |
4 |
| Northwestern University | 3389 |
4 |
| Abbott Healthcare Products B.V. | 45 |
4 |
| Changzhou Tronly Advanced Electronic Materials Co., Ltd. | 77 |
4 |
| Changzhou Tronly New Electronic Materials Co.,Ltd. | 76 |
4 |
| Emory University | 1626 |
4 |
| Laboratorios Del Dr. Esteve, S.A. | 166 |
4 |
| Solvay Pharmaceuticals B.V. | 23 |
4 |
| Novo Nordisk A/S | 2282 |
4 |
| Other owners | 133 |